Please assess the completion status of the following clinical trial:

Trial Title: Intravenous (IV) Nitroglycerin for Versions in Nulliparous Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* any non-cephalic presentation~* singleton pregnancy~* \>/= 37 weeks gestational age~* normal amniotic fluid volume~* reassuring fetal heart rate~Exclusion Criteria:~* labor~* ruptured membranes~* history of third trimester bleeding~* any pre-existing uterine scar~* pregnancy induced hypertension and gestational diabetes~* oligohydramnios and polyhydramnios~* intrauterine growth restriction or macrosomia~* hypotension or any serious medical illness~* inability to comprehend the consent form

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Treatment solution consisted of 100 micrograms/mL of nitroglycerin. After an initial 1ml dose, further doses could be given in 1-3mL increments until uterine relaxation was achieved, or up to a recommended maximum of 10mL
- 2 (Type: PLACEBO_COMPARATOR): Placebo solution was saline. After an initial 1ml dose, further doses could be given in 1-3mL increments until uterine relaxation was achieved, or up to a recommended maximum of 10mL

Based on this trial design, predict the completion outcome and termination type (if applicable).